CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 47 enrolled
Drug / intervention
Tramadol Contramid® OAD 200mgdrug
Likely dose
Tramadol Contramid® OAD 200mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00952068
NCT00952068Phase 2Completed
CompareCT.gov

A Pharmacodynamic/Pharmacokinetic Study to Determine the Onset of Analgesic Effect and Plasma Levels of Tramadol in Patients With Acute Low Back Pain Receiving a Single 200 mg Dose of Tramadol Contramid® Once-a-Day

Labopharm Inc.·interventional·Posted Aug 4, 2009·Updated Apr 30, 2012

In Brief

A Phase 2 clinical trial evaluating Tramadol Contramid® OAD 200mg for Acute Low Back Pain. Completed, enrolled 47 participants.

Detailed Summary

The primary objective of this study is to determine the time of onset of analgesic effect of Tramadol Contramid® Once-A-Day (OAD) in acute low back pain. Secondary objectives include determining the relationship between analgesic effect and plasma levels for Tramadol Contramid® OAD and to examine safety after single dose administration of 200 mg of Tramadol Contramid® OAD.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Low Back Pain
Countries--
Collaborators--

Timeline

Phase 2CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedAug 4, 2009
Enrollment StartJan 1, 2007
Primary CompletionApr 1, 2007
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 16.9 years ago

Interventions

Tramadol Contramid® OAD 200mgdrug

1 Tramadol Contramid® OAD 200mg tablet daily.